GeneDx Holdings Corp. (WGS)

NMS – Real Time Price. Currency in USD

82.25

+0.51 (0.62%)

Market open: Aug 12, 2026, 11:36 AM EDT

80.11

-1.63 (-1.99%)

Previous after-hours: Aug 11, 2026, 7:58 PM EDT

06.08.2026

GeneDx to Participate in Upcoming Investor Conferences

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS) announced that company management will participate in the Canaccord Genuity and Wells Fargo investor conferences.

06.08.2026

Alger Small Cap Focus Fund Q2 2026 Portfolio Review

Nebius Group, Credo Technology Group, and Guardant Health, Inc. were among the top contributors to performance. During the quarter, Credo shares contributed positively to performance as investors responded favorably to the company's rapid revenue growth and rising demand from hyperscale customers. Karman Holdings Inc., GeneDx Holdings Corp., and Forte Biosciences Inc. were among the top detractors from performance.

04.08.2026

GeneDx Holdings Corp. (WGS) Q2 2026 Earnings Call Transcript

03.08.2026

GeneDx Q2 Earnings Call Highlights

GeneDx NASDAQ: WGS reported second-quarter revenue of $114.4 million, above its prior guidance, as exome and genome testing volume reached a quarterly record of more than 30,000 tests. The company also returned to adjusted profitability one quarter earlier than previously expected, while maintaining its full-year 2026 outlook.

03.08.2026

GeneDx Holdings Corp. (WGS) Q2 Earnings and Revenues Surpass Estimates

GeneDx Holdings Corp. (WGS) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.19 per share. This compares to earnings of $0.5 per share a year ago.

03.08.2026

GeneDx Reports Second Quarter 2026 Financial Results

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS) today reported its financial and operational results for the second quarter of 2026.

03.08.2026

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

New York, New York--(Newsfile Corp. - August 3, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired GeneDx securities between April 16, 2025 and May 4, 2026, both dates inclusive (the "Class Period").

Videos

No Data

There is no data to display

Press releases

03.08.2026

GeneDx Reports Second Quarter 2026 Financial Results

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS) today reported its financial and operational results for the second quarter of 2026.

03.08.2026

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

03.08.2026

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

NEW YORK--(BUSINESS WIRE)---- $WGS #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ: WGS) and reminds investors of the August 3, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm h.

03.08.2026

WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with SBS Law

LOS ANGELES, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GeneDx Holdings Corp. (“GeneDx” or “the Company”) (NASDAQ: WGS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of WGS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

GeneDx Holdings Corp. (WGS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

GeneDx Holdings Corp. (WGS)

GeneDx to Participate in Upcoming Investor Conferences

Alger Small Cap Focus Fund Q2 2026 Portfolio Review

GeneDx Holdings Corp. (WGS) Q2 2026 Earnings Call Transcript

GeneDx Q2 Earnings Call Highlights

GeneDx Holdings Corp. (WGS) Q2 Earnings and Revenues Surpass Estimates

GeneDx Reports Second Quarter 2026 Financial Results

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

Videos

No Data

Press releases

GeneDx Reports Second Quarter 2026 Financial Results

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with SBS Law

GeneDx to Participate in Upcoming Investor Conferences

Alger Small Cap Focus Fund Q2 2026 Portfolio Review

GeneDx Holdings Corp. (WGS) Q2 2026 Earnings Call Transcript

GeneDx Q2 Earnings Call Highlights

GeneDx Holdings Corp. (WGS) Q2 Earnings and Revenues Surpass Estimates

GeneDx Reports Second Quarter 2026 Financial Results

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

Videos

No Data

Press releases

GeneDx Reports Second Quarter 2026 Financial Results

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with SBS Law

Search stocks

GeneDx Holdings Corp. (WGS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

GeneDx Holdings Corp. (WGS)

GeneDx to Participate in Upcoming Investor Conferences

Alger Small Cap Focus Fund Q2 2026 Portfolio Review

GeneDx Holdings Corp. (WGS) Q2 2026 Earnings Call Transcript

GeneDx Q2 Earnings Call Highlights

GeneDx Holdings Corp. (WGS) Q2 Earnings and Revenues Surpass Estimates

GeneDx Reports Second Quarter 2026 Financial Results

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

Videos

No Data

Press releases

GeneDx Reports Second Quarter 2026 Financial Results

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with SBS Law

GeneDx to Participate in Upcoming Investor Conferences

Alger Small Cap Focus Fund Q2 2026 Portfolio Review

GeneDx Holdings Corp. (WGS) Q2 2026 Earnings Call Transcript

GeneDx Q2 Earnings Call Highlights

GeneDx Holdings Corp. (WGS) Q2 Earnings and Revenues Surpass Estimates

GeneDx Reports Second Quarter 2026 Financial Results

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

Videos

No Data

Press releases

GeneDx Reports Second Quarter 2026 Financial Results

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with SBS Law